- Home
- IROQ vs VERU Comparison
IROQ vs VERU Comparison
Compare IROQ & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IROQ
- VERU
- Stock Information
- Founded
- IROQ 1883
- VERU 1971
- Country
- IROQ United States
- VERU United States
- Employees
- IROQ N/A
- VERU N/A
- Industry
- IROQ Savings Institutions
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- IROQ Finance
- VERU Health Care
- Exchange
- IROQ Nasdaq
- VERU Nasdaq
- Market Cap
- IROQ 77.5M
- VERU 74.6M
- IPO Year
- IROQ 2011
- VERU 1990
- Fundamental
- Price
- IROQ $24.31
- VERU $0.58
- Analyst Decision
- IROQ
- VERU Strong Buy
- Analyst Count
- IROQ 0
- VERU 2
- Target Price
- IROQ N/A
- VERU $4.00
- AVG Volume (30 Days)
- IROQ 1.0K
- VERU 3.4M
- Earning Date
- IROQ 04-29-2025
- VERU 05-08-2025
- Dividend Yield
- IROQ 1.64%
- VERU N/A
- EPS Growth
- IROQ 69.23
- VERU N/A
- EPS
- IROQ 1.05
- VERU N/A
- Revenue
- IROQ $25,099,000.00
- VERU $16,886,419.00
- Revenue This Year
- IROQ N/A
- VERU N/A
- Revenue Next Year
- IROQ N/A
- VERU N/A
- P/E Ratio
- IROQ $23.21
- VERU N/A
- Revenue Growth
- IROQ 12.02
- VERU 134.43
- 52 Week Low
- IROQ $14.85
- VERU $0.45
- 52 Week High
- IROQ $25.76
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- IROQ 52.54
- VERU 63.23
- Support Level
- IROQ $24.21
- VERU $0.48
- Resistance Level
- IROQ $24.53
- VERU $0.67
- Average True Range (ATR)
- IROQ 0.09
- VERU 0.04
- MACD
- IROQ 0.01
- VERU 0.01
- Stochastic Oscillator
- IROQ 43.21
- VERU 51.11
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.